Retrogen Inc.

Retrogen, Inc. performs testing of FDA approved protocols for Emergency Use Authorization (EUA) for COVID 19 testing and complies with the Centers for Disease Control and Prevention (CDC) guidelines on social distancing and enhanced cleaning procedures to ensure the health of our patients, employees, and others.

Our test utilizes direct real-time RT-PCR assay is intended for the use in detection of nucleic acid from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasal swabs (Anterior Nasal) specimens. COVID 19 Direct assay is an aid in the diagnosis of SARS-CoV-2 infection.